Cardiac MIBG Scintigraphy in Neurodegenerative Parkinsonism: Limitations in Clinical Practice
Movement Disorders Clinical Practice · 2026
DOI: 10.1002/mdc3.70656 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2026. Verfasst von Frank Jagusch und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. Hauptthemen laut MEDLINE: 3-Iodobenzylguanidine, Supranuclear Palsy, Progressive, Parkinsonian Disorders, Multiple System Atrophy. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Reduced cardiac uptake on 123 Iodine‐metaiodobenzylguanidine (MIBG) scintigraphy is a valuable tool for differentiating neurodegenerative parkinsonism but interpretation can be difficult due to comorbidities and drug‐tracer interactions.
Objectives
This study investigated factors limiting the clinical applicability of MIBG scintigraphy in everyday clinical practice.
Methods
Patient records (2021–2022) were retrospectively reviewed, independent of whether MIBG scintigraphy was performed, for comorbidities and concomitant medication confounding its interpretation.
Results
Six hundred ninety five patients (640 Parkinson's disease, 22 multiple system atrophy, 33 progressive supranuclear palsy) were included. Factors potentially influencing cardiac MIBG binding were present in 55.3% with 18.1% exhibiting multiple factors. Medications with known drug‐tracer interactions were found in 46.9% and comorbidities associated with reduced cardiac MIBG uptake in 20.9%.
Conclusions
The clinical utility of MIBG scintigraphy is frequently restricted by medications and comorbidities highlighting the need of careful planning in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
ORCID-Profile: Frank Jagusch, Christoph Theyer, Alessandra Fanciulli, Philipp Mahlknecht, Beatrice Heim, Florian Krismer
Zitieren
APA
Jagusch, F., Redl, E., Theyer, C., Djamshidian, A., Fanciulli, A., Poewe, W., Mahlknecht, P., Heim, B., Seppi, K., & Krismer, F. (2026). Cardiac MIBG Scintigraphy in Neurodegenerative Parkinsonism: Limitations in Clinical Practice. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70656
Vancouver
Jagusch F, Redl E, Theyer C, Djamshidian A, Fanciulli A, Poewe W, et al. Cardiac MIBG Scintigraphy in Neurodegenerative Parkinsonism: Limitations in Clinical Practice. Movement Disorders Clinical Practice. 2026. doi:10.1002/mdc3.70656
BibTeX
@article{Jagusch2026,
author = {Jagusch, Frank and Redl, Elena and Theyer, Christoph and Djamshidian, Atbin and Fanciulli, Alessandra and Poewe, Werner and Mahlknecht, Philipp and Heim, Beatrice and Seppi, Klaus and Krismer, Florian},
title = {Cardiac MIBG Scintigraphy in Neurodegenerative Parkinsonism: Limitations in Clinical Practice},
journal = {Movement Disorders Clinical Practice},
year = {2026},
doi = {10.1002/mdc3.70656}
}
EUVIMED